Biography:
Zohar is currently leading the R & D team at Fore. Zohar graduated from Tel-Aviv University in 2009, in the area of RNA editing and human genetics. Following a PhD she went through postdoctoral education at NIH in the field of epigenetics, focusing on epigenetics markers in mice models for immunology and cancer. Dr Barbash returned to Israel in 2013 to continue her career as a PhD level executive with extensive experience in molecular and cellular biology. First, working in pre-clinical in-vivo and in-vitro experiences at EventusDX that developed breast cancer diagnostics, and then at NovellusDx, that developed a high thruput precision medicine platform for cancer diagnostics and therapeutics. NovellusDX has changed its name and purpose becoming an international drug development company, using the Novellus Platform. Zohar was appointed as VP of research at Fore. Dr. Barbash is a highly motivated natural leader with experience in leading teams of researchers from multidisciplinary backgrounds into development of products and clinical trial under all the needed quality assuring steps and regulations. Experienced in management of budgets, human resources, quality, and regulation.
Title : Novel peptides as food ingredient for weight management